Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines … RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, ... Alzheimer's & dementia 7 (3), 280-292, 2011 | 7986 | 2011 |
NIA-AA research framework: toward a biological definition of Alzheimer's disease CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, B Dunn, SB Haeberlein, ... Alzheimer's & Dementia 14 (4), 535-562, 2018 | 7243 | 2018 |
Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... New England Journal of Medicine 367 (9), 795-804, 2012 | 3998 | 2012 |
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease RL Buckner, J Sepulcre, T Talukdar, FM Krienen, H Liu, T Hedden, ... Journal of neuroscience 29 (6), 1860-1873, 2009 | 3012 | 2009 |
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ... Alzheimer's & dementia 10 (6), 844-852, 2014 | 2492 | 2014 |
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease CR Jack Jr, MS Albert, DS Knopman, GM McKhann, RA Sperling, ... Alzheimer's & dementia 7 (3), 257-262, 2011 | 2316 | 2011 |
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ... New England Journal of Medicine 370 (4), 322-333, 2014 | 2062 | 2014 |
Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1778 | 2016 |
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1764 | 2016 |
Alzheimer's disease CL Masters, R Bateman, K Blennow, CC Rowe, RA Sperling, ... Nature reviews disease primers 1 (1), 1-18, 2015 | 1754 | 2015 |
A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, HH Feldman, GB Frisoni, ... Neurology 87 (5), 539-547, 2016 | 1551 | 2016 |
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in … BC Dickerson, A Bakkour, DH Salat, E Feczko, J Pacheco, DN Greve, ... Cerebral cortex 19 (3), 497-510, 2009 | 1149 | 2009 |
Amyloid deposition is associated with impaired default network function in older persons without dementia RA Sperling, PS LaViolette, K O'Keefe, J O'Brien, DM Rentz, ... Neuron 63 (2), 178-188, 2009 | 1091 | 2009 |
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report PT Nelson, DW Dickson, JQ Trojanowski, CR Jack, PA Boyle, K Arfanakis, ... Brain 142 (6), 1503-1527, 2019 | 1044 | 2019 |
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD BC Dickerson, DH Salat, DN Greve, EF Chua, E Rand-Giovannetti, ... Neurology 65 (3), 404-411, 2005 | 1020 | 2005 |
Tau positron emission tomographic imaging in aging and early A lzheimer disease KA Johnson, A Schultz, RA Betensky, JA Becker, J Sepulcre, D Rentz, ... Annals of neurology 79 (1), 110-119, 2016 | 977 | 2016 |
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease S Salloway, R Sperling, S Gilman, NC Fox, K Blennow, M Raskind, ... Neurology 73 (24), 2061-2070, 2009 | 910 | 2009 |
Brain imaging in Alzheimer disease KA Johnson, NC Fox, RA Sperling, WE Klunk Cold Spring Harbor perspectives in medicine 2 (4), a006213, 2012 | 866 | 2012 |
Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis KA Celone, VD Calhoun, BC Dickerson, A Atri, EF Chua, SL Miller, ... Journal of Neuroscience 26 (40), 10222-10231, 2006 | 857 | 2006 |
The A4 study: stopping AD before symptoms begin? RA Sperling, DM Rentz, KA Johnson, J Karlawish, M Donohue, ... Science translational medicine 6 (228), 228fs13-228fs13, 2014 | 746 | 2014 |